跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Unidocet-20 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Unidocet-20
Approved
STANDARD
Unidocet-20
ADMAC Lifesciences
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
95f23771fca85dc0
Company
ADMAC Lifesciences
Type
Standard
Approval Details
Approval Id
95f23771fca85dc0
Drug Approval Philippines Name
Unidocet-20
Product Name
Unidocet-20
Registration Number
DRP-12719
Brand Name
Unidocet-20
Generic Name
Docetaxel (as trihydrate)
Dosage Form
Concentrate for Solution for IV Infusion
Dosage Strength
20 mg/0.5 mL
Manufacturer
ADMAC Lifesciences
Importer
AGB Pharmaceutical Trading and Consultancy Corporation
Distributor
AGB Pharmaceutical Trading and Consultancy Corporation
Issuance Date
28 September 2022
Expiry Date
28 September 2027
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
95f23771fca85dc0
Type
Standard
Back to Philippines FDA Approvals